Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
Open Access
- 7 October 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10) , e26045
Abstract
Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra and the aggregation of α-synuclein into Lewy bodies. Existing therapies address motor dysfunction but do not halt progression of the disease. A still unresolved question is the biochemical pathway that modulates the outcome of protein misfolding and aggregation processes in PD. The molecular chaperone network plays an important defensive role against cellular protein misfolding and has been identified as protective in experimental models of protein misfolding diseases like PD. Molecular mechanisms underlying chaperone-neuroprotection are actively under investigation. Current evidence implicates a number of molecular chaperones in PD including Hsp25, Hsp70 and Hsp90, however their precise involvement in the neurodegenerative cascade is unresolved. The J protein family (DnaJ or Hsp40 protein family) has long been known to be important in protein conformational processes. We assessed sensory and motor function of control and PD rats and then evaluated the brain region-specific expression levels of select J proteins by Western analysis. Surprisingly, we observed a widespread 26 kDa breakdown product of the J protein, TID1, (tumorous imaginal discs, mtHsp40 or DnaJ3) in a 6-hydroxydopamine (6-OHDA) rat model of PD in which food handling, gait symmetry and sensory performance were impaired. Greater behavioral deficits were associated with lower TID1 expression. Furthermore, direct application of either 6-OHDA or MPP+ (1-methyl-4-phenylpyridinum) to CAD (CNS-derived catecholinaminergic neuronal cell line) cell cultures, reduced TID1 expression levels. Our results suggest that changes in cellular TID1 are a factor in the pathogenesis of PD by impeding functional and structural compensation and exaggerating neurodegenerative processes. In contrast, no changes were observed in CSPα, Hsp40, Hsp70, Hsc70 and PrPC levels and no activation of caspase3 was observed. This study links TID1 to PD and provides a new target for therapeutics that halts the PD progression.Keywords
This publication has 69 references indexed in Scilit:
- Molecular chaperones in protein folding and proteostasisNature, 2011
- Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by HipThe EMBO Journal, 2009
- α‐Synuclein abnormalities in mouse models of peroxisome biogenesis disordersJournal of Neuroscience Research, 2009
- A Mammalian Homolog of Drosophila Tumorous Imaginal Discs, Tid1, Mediates Agrin Signaling at the Neuromuscular JunctionNeuron, 2008
- Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril AssemblyBiochemistry, 2008
- Heat shock factor 1 regulates lifespan as distinct from disease onset in prion diseaseProceedings of the National Academy of Sciences, 2008
- The Vermicelli Handling Test: A simple quantitative measure of dexterous forepaw function in ratsJournal of Neuroscience Methods, 2008
- Prion protein attenuates excitotoxicity by inhibiting NMDA receptorsJournal of Cell Biology, 2008
- The Role of the Octarepeat Region in Neuroprotective Function of the Cellular Prion ProteinBrain Pathology, 2007
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005